Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
about
Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathyT and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.Thyroid eye disease.Is endocrine ophthalmopathy related to smoking?The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, MinnesotaThe ophthalmopathy of Graves' diseaseDefinition, at the molecular level, of a thyroglobulin-acetylcholinesterase shared epitope: study of its pathophysiological significance in patients with Graves' ophthalmopathy.Thyroid-associated ophthalmopathy.Diabetes mellitus: a risk factor in patients with Graves' orbitopathyT cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathyRole of connective tissue autoimmunity in Graves' ophthalmopathy.Glycosaminoglycans in thyroid-associated ophthalmopathy.Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.Intravenous methylprednisolone in the treatment of Graves' ophthalmopathyDysthyroid optic neuropathy (DON).Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls.Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging.Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy.Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in graves' disease.Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.Immunologically mediated cytotoxicity against human eye muscle and thyroid cells in euthyroid and thyrotoxic Graves' ophthalmopathy.Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.More on smoking habits and Graves' ophthalmopathy.Long-term observation of endocrine ophthalmopathy and retrospective appraisal of therapeutic measures.A study of the binding of Graves' immunoglobulins to orbital antigens.The tear cytokine profile in patients with active Graves' orbitopathy.Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.
P2860
Q30461261-A225CFB2-7163-4A1A-9FAB-908D1F323343Q33647132-1EE161AB-829A-48DB-B080-48053F6F1DCAQ33647383-58EE4F07-5030-49AB-9646-2E614DEA9C7CQ33887285-EB650F96-4632-4011-94FF-62DBE1E7408FQ34085245-D576DCE4-D824-4DAB-9673-36DABBB6FC61Q34164149-24A2AE84-2AED-417F-ACBB-4E0C5BC61BAEQ34192108-C12D9910-DCA6-45A1-9201-7BE72326A4C7Q35172325-BDB08F82-431D-43DB-A083-086D888174CEQ35246094-21DDEDC6-B60A-4C97-8E3C-05D5A5952B9BQ35309685-C248BD66-2938-4BF5-8B3F-A45CEF925B85Q35314277-2D4311BA-4231-4B28-BF68-DBCDF9CB6465Q35462736-A7E9D65F-4071-457B-B7FC-F5E9FCB746D1Q35462752-67E03E41-549C-443F-AC36-8365CEDD062AQ35592595-D4DA468A-E04D-4341-B3B7-A03075811C65Q35706662-A4F00C0A-C0E8-4F1E-84E4-A4929674256EQ35932490-861D6E95-606E-4C3F-80C3-6FDCA7ECCF0EQ35937585-349BED77-D724-4E6F-BC18-CE665764912EQ36070800-9E8399ED-95F0-465A-B73E-9F695C84DB67Q36181924-0CB76B5A-C054-4A0D-BE25-DCB497948227Q36337247-78683065-BD47-40FB-B0D8-7B81259D61ACQ37108158-5860C059-9D0B-4C0B-BCD9-2A3FAD101114Q37303872-FDC57144-B741-4942-9F19-762E6FDD24A3Q38408737-D8A5EC89-A20B-4156-8E56-B597B77FB72AQ40018141-FCF4EBCA-05AC-49FF-B9C5-29442EF1E7E6Q40893670-70AFAF7D-3F88-427D-89D2-F80896F6411FQ43470789-C1324872-E236-41F9-935A-500BBBDEFDE0Q43758895-821943E3-FE13-4206-831A-E4D3FB0D738DQ44402083-630114C6-D993-46E4-9E9A-F7841CB31E28Q44906164-84094970-52DB-4610-A35E-F2D105C05319Q45030482-FB30FFF1-F75B-4856-A53A-CFFD571F75A3Q46312069-D5ECCB47-42F1-4E93-930D-B94B0CF52C62Q47576886-9FC7BA5C-A714-4D1A-87ED-6B4550E322E2Q52117482-1877F293-7E7F-4F8C-8C1D-08D71C6F2D9EQ54334608-D35DC1CF-E5D5-427A-9A9E-66C5AC290C30
P2860
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
@en
type
label
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
@en
prefLabel
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
@en
P356
P1433
P1476
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
@en
P2093
Jacobson DH
P304
P356
10.1210/EDRV-5-2-200
P577
1984-01-01T00:00:00Z